Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

FTSE 100 flat as heavyweights trading ex-div offset gains from GDP data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>FTSE 100 flat as heavyweights trading ex-div offset gains from GDP data</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

FTSE 100 flat, FTSE 250 off 0.2%

Aug 15 (Reuters) -The UK's benchmark index FTSE 100 was flat on Thursday as gains from an in-line UK GDP data, showing a still-healthy economy, were offset by losses in companies that traded without entitlement to their latest dividend payouts.

The bluechip FTSE 100 .FTSE was flat as of 0711 GMT after logging four sessions of gains, while the midcap FTSE 250 .FTMC was down 0.2%.

Britain's economy grew 0.6% in the second quarter of 2024, in line with economists' expectations and building on a rapid 0.7% recovery in the first quarter of the year after a shallow recession in the second half of 2023.

"It's worth noting that June's GDP figure was completely flat, which might initially raise concerns. However, this could actually provide the Bank of England with further justification to consider cutting interest rates next month," said Sam North, market analyst at investment platform eToro.

The pound GBP= was higher against the U.S. dollar and money markets still see a 40% chance of BoE cutting rates by 25 basis points in September. 0#BOEWATCH

Overall, the investor sentiment remained sanguine partly after the benign U.S. consumer inflation data overnight reinforced bets for the Federal Reserve to start cutting interest rates next month.

Among sectors, industrial metal miners .FTNMX551020 slid 1.1%, on track for its third session of declines, as Rio Tinto RIO.L and Anglo American AAL.L traded ex-dividend.

Admiral Group ADML.L jumped 11.6% after the motor and home insurer posted a forecast-beating 32% rise in pre-tax profit for the first half of the year, and said it would pay a special dividend.

Index heavyweight AstraZeneca AZN.L was up 0.8% after the U.S. Food and Drug Administration (FDA) granted its blockbuster cancer drug Imfinzi a priority review for patients with limited-stage small cell lung cancer in the United States.

HSBC HSBA.L, Barclays BARC.L, and Entain ENT.L were among the bottom performers as these companies also traded without entitlement to their latest dividend payouts.






Reporting by Shubham Batra in Bengaluru; Editing by Eileen Soreng

 For related prices, Reuters users may click on - * UK stock report .L FTSE index: 0#.FTS6 techMARK 100 index: .FTT1X FTSE futures: 0#FFI: Gilt futures: 0#FLG: Smallcap index: .FTSC FTSE 250 index: .FTMC FTSE 350 index: .FTLC Market digest: .AD.L Top 10 by vol: .AV.L Top price gainers: .NG.L Top % gainers: .PG.L Top price losers: .NL.L Top % losers: .PL.L * For related news, click on - * UK hot stocks: HOT and GB Wall Street: .N Gilts report: GB/ Euro bond report GVD/EUR Pan European stock report: .EU Tokyo stocks: .T HK stocks: .HK Sterling report: GBP/ Dollar report: USD/ * For company prices, click on - * Company directory: UKEQ By sector: FTAX * For pan-European market data, click on - * European Equities speed guide................ EUR/EQUITY FTSE Eurotop 300 index........................... .FTEU3 DJ STOXX index................................... .STOXX Top 10 STOXX sectors........................ .PGL.STOXXS Top 10 EUROSTOXX sectors................... .PGL.STOXXES Top 10 Eurotop 300 sectors.................. .PGL.FTEU3S Top 25 European pct gainers.................... .PG.PEUR Top 25 European pct losers..................... .PL.PEUR
</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.